Cyanamid L500 expands market presence in India
In recent years, India has developed into an important and excellent producer of generic drugs for the global pharmaceutical industry. Pharmaceutical companies on the subcontinent are increasingly sourcing their raw materials from Europe, or more precisely from Upper Bavaria. Thanks to its well-known high product quality, Cyanamid L500 from Alzchem is also finding more and more interested parties in the Indian market.
Alzchem's Cyanamid L500 is delivered quickly, safely and on schedule to the desired production sites via a stable logistics chain. Alzchem's many years of experience and the cooperation with its exclusive Indian distribution partner Chemet result in maximum reliability - in terms of both quality and logistics.
Contact
Josef Niedermaier
About Alzchem
Alzchem is a globally active specialty chemicals company that is predominantly among the market leaders in its fields of activity. Alzchem benefits in particular from the three very different global developments of climate change, population growth and longer life expectancy. In order to achieve the resulting social goals, Alzchem products can offer attractive solutions with a wide range of different applications.
The company sees interesting growth prospects for itself especially in the areas of human and animal nutrition and agriculture. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and our creatine products can contribute to healthy aging as life expectancy increases. Alzchem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective.
The broad product range of Alzchem Group AG includes dietary supplements, precursors for corona tests and pharmaceutical raw materials. These products are our company’s response to global trends and developments. Alzchem is ideally positioned in this regard and sees itself as well equipped for an environmentally oriented future and global developments.
The company employs around 1,630 people at four production sites in Germany and one plant in Sweden, as well as two sales companies in the USA and China. In 2020, Alzchem generated consolidated sales of around EUR 379 million and EBITDA of around EUR 53.8 million.